Rogel Cancer Center

Ann Arbor, Michigan 48109-2800

1 studies enrolling now · 5 studies all time

What they study most

Adenosquamous Carcinoma, Biliary Tract Cancer, Breast Neoplasms, Gastrointestinal Neuroendocrine Carcinoma, Gastrointestinal Neuroendocrine Tumor, Metastatic Pancreatic Adenocarcinoma, Neuroendocrine Prostate Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Tumor, Prostate Cancer

Studies at this site

• COMPASS Study for Metastatic Castration-resistant Prostate Cancer — Recruiting now
• Multicenter Trial of ESK981 in Patients With Select Solid Tumors — Running, not enrolling
• Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy — Completed
• Early Detection of Breast Cancer — Status unconfirmed
• Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas — Withdrawn before enrolling